| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 28, 2026 and February 28, 2025:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended February 28, |
|
|
|
2026 |
|
|
2025 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,643,113 |
|
|
$ |
7,865,888 |
|
PrepaCyte CB |
|
|
38,594 |
|
|
|
20,913 |
|
Public cord blood banking |
|
|
1,410 |
|
|
|
82,079 |
|
Total net revenue |
|
$ |
7,683,117 |
|
|
$ |
7,968,880 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,544,001 |
|
|
$ |
1,701,635 |
|
PrepaCyte CB |
|
|
12,187 |
|
|
|
6,959 |
|
Public cord blood banking |
|
|
100,300 |
|
|
|
275,994 |
|
Total cost of sales |
|
$ |
1,656,488 |
|
|
$ |
1,984,588 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
837,865 |
|
|
$ |
1,242,917 |
|
PrepaCyte CB |
|
|
26,159 |
|
|
|
7,009 |
|
Public cord blood banking |
|
|
(98,890 |
) |
|
|
(193,915 |
) |
Total operating profit |
|
$ |
765,134 |
|
|
$ |
1,056,011 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
183,639 |
|
|
$ |
184,908 |
|
PrepaCyte CB |
|
|
248 |
|
|
|
6,945 |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total depreciation and amortization |
|
$ |
183,887 |
|
|
$ |
191,853 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
462,709 |
|
|
$ |
494,962 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
462,709 |
|
|
$ |
494,962 |
|
The following table shows the assets by segment as of February 28, 2026 and November 30, 2025:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
February 28, 2026 |
|
|
November 30, 2025 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
59,940,047 |
|
|
$ |
60,788,322 |
|
PrepaCyte CB |
|
|
140,900 |
|
|
|
135,379 |
|
Public cord blood banking |
|
|
804,039 |
|
|
|
804,813 |
|
Total assets |
|
$ |
60,884,986 |
|
|
$ |
61,728,514 |
|
|